1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32024
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPeyton, Philip J-
dc.contributor.authorLiskaser, Grace-
dc.contributor.authorHo, Alexander-
dc.contributor.authorMarsh, Harry-
dc.contributor.authorEtherington, Christopher-
dc.contributor.authorTorlot, Freddie-
dc.contributor.authorDesai, Manisha-
dc.contributor.authorPerrett, George-
dc.contributor.authorChee, Brian-
dc.contributor.authorLeslie, Kate-
dc.contributor.authorMyles, Paul S-
dc.date2023-
dc.date.accessioned2023-01-24T03:20:08Z-
dc.date.available2023-01-24T03:20:08Z-
dc.date.issued2023-01-16-
dc.identifier.citationAnesthesiology 2023-04-01; 138(4)-
dc.identifier.issn1528-1175-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32024-
dc.description.abstractNitrous oxide (N2O) promotes absorption atelectasis in poorly ventilated lung segments at high inspired concentrations. The ENIGMA Trial found a higher incidence of postoperative pulmonary complications (PPCs) and wound sepsis with N2O anesthesia in major surgery compared to FIO2 0.8 without N2O. The larger ENIGMA II trial randomised patients to N2O or air at FIO2 0.3 but found no effect on wound infection or sepsis. However, postoperative pulmonary complications were not measured. In the current study we collected post hoc data to determine if atelectasis and pneumonia incidences were higher with N2O in patients who were recruited to the Australian cohort of ENIGMA II.-
dc.language.isoeng-
dc.titlePostoperative pulmonary complications in the ENIGMA II Trial: A post hoc analysis.-
dc.typeJournal Articleen_US
dc.identifier.journaltitleAnesthesiology-
dc.identifier.affiliationAustin Health-
dc.identifier.affiliationBarwon Health, Geelong, Victoria, Australia.-
dc.identifier.affiliationRoyal Perth Hospital, Perth, Western Australia.-
dc.identifier.affiliationFremantle Hospital, Fremantle, Western Australia.-
dc.identifier.affiliationWestmead Hospital, Sydney, New South Wales, Australia.-
dc.identifier.affiliationDept of Critical Care, Melbourne Medical School, University of Melbourne, Victoria, Australia.-
dc.identifier.affiliationThe Alfred, Melbourne, Victoria, Australia.-
dc.identifier.doi10.1097/ALN.0000000000004497-
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-1185-2869-
dc.identifier.pubmedid36645804-
dc.description.volume138-
dc.description.issue4-
dc.description.startpage354-
dc.description.endpage363-
dc.subject.meshtermssecondaryAustralia/epidemiology-
dc.subject.meshtermssecondaryNitrous Oxide/adverse effects-
dc.subject.meshtermssecondaryPostoperative Complications/etiology-
dc.subject.meshtermssecondaryPulmonary Atelectasis/epidemiology-
dc.subject.meshtermssecondaryPulmonary Atelectasis/etiology-
dc.subject.meshtermssecondaryPneumonia/epidemiology-
dc.subject.meshtermssecondaryAnesthesia, General/adverse effects-
local.name.researcherMarsh, Harry
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
crisitem.author.deptAnaesthesia-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptAnaesthesia-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

50
checked on Jun 4, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.